Reactive oxygen species (ROS) constantly generated inside the body are required to drive regulatory pathways and are also a cause for several pathological conditions including cancer. Numerous lines of evidence suggest that ROS can promote as well as suppress the survival of cancer cells. First, ROS are known to regulate each and every step of tumor development including transformation, survival, proliferation, invasion, metastasis, and angiogenesis. Second, chronic inflammation, one of the major mediators of cancer, is regulated by ROS. Third, ROS are known to regulate signaling molecules required for cell cycle progression. Fourth, the expression of various tumor suppressor genes is under control of ROS. Fifth, a high level of ROS can suppress tumor growth through the sustained activation of the cell cycle inhibitors. Sixth, most of the currently available chemotherapeutic and radiotherapeutic agents kill cancer cells by increasing ROS stress. Thus, both ROS-elevating and ROS-eliminating strategies have been developed for cancer therapy.
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This special issue is an effort to assess the existing concepts, recent findings, controversies, and challenges concerning the role of ROS in tumor development. In particular, the topics covered in this special issue include understanding the role of ROS in cancer initiation and progression (M. Tafani It is our hope that these articles will be useful to the readers.
